GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Easy Bio Inc (XKRX:353810) » Definitions » Cash-to-Debt

Easy Bio (XKRX:353810) Cash-to-Debt : N/A (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Easy Bio Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Easy Bio's cash to debt ratio for the quarter that ended in Mar. 2024 was N/A.

The historical rank and industry rank for Easy Bio's Cash-to-Debt or its related term are showing as below:

During the past 4 years, Easy Bio's highest Cash to Debt Ratio was 0.66. The lowest was 0.00. And the median was 0.38.

XKRX:353810's Cash-to-Debt is not ranked *
in the Biotechnology industry.
Industry Median: 6.85
* Ranked among companies with meaningful Cash-to-Debt only.

Easy Bio Cash-to-Debt Historical Data

The historical data trend for Easy Bio's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Easy Bio Cash-to-Debt Chart

Easy Bio Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
0.60 0.43 0.50 0.37

Easy Bio Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.41 0.37 0.36 0.37 N/A

Competitive Comparison of Easy Bio's Cash-to-Debt

For the Biotechnology subindustry, Easy Bio's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Easy Bio's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Easy Bio's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Easy Bio's Cash-to-Debt falls into.



Easy Bio Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Easy Bio's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Easy Bio's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Easy Bio  (XKRX:353810) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Easy Bio Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Easy Bio's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Easy Bio (XKRX:353810) Business Description

Traded in Other Exchanges
N/A
Address
310, Gangnam-daero, 4th Floor, Gangnam-gu, Seoul, KOR, 06253
Easy Bio Inc is a bio-technology company. The company conducts research, manufactures and markets animal feed products in South Korea.

Easy Bio (XKRX:353810) Headlines

No Headlines